ExpreS2ion Biotech Holding AB (EXPRS2) — Net Asset Quality Index
ExpreS2ion Biotech Holding AB (EXPRS2) has a Net Asset Quality Index of 54.8% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of Skr65.11 Million minus total liabilities of Skr29.42 Million yields net assets of Skr35.69 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check ExpreS2ion Biotech Holding AB liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
ExpreS2ion Biotech Holding AB Net Asset Quality Index Over Time (2013–2025)
This chart shows how ExpreS2ion Biotech Holding AB's Net Asset Quality Index has evolved across 13 annual periods from 2013 to 2025. As of December 2025, the index stands at 54.8%, representing net assets of Skr35.69 Million against total assets of Skr65.11 Million SEK. See EXPRS2 net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for ExpreS2ion Biotech Holding AB (2013–2025)
The table below presents the year-by-year Net Asset Quality Index for ExpreS2ion Biotech Holding AB from 2013 to 2025, covering 13 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see ExpreS2ion Biotech Holding AB stock valuation.
| Year | Quality Index | Net Assets (SEK) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 54.8% | Skr35.69 Million | Skr65.11 Million | Skr29.42 Million | ▼ -6.8 pp |
| 2024 | 61.6% | Skr64.42 Million | Skr104.53 Million | Skr40.11 Million | ▼ -21.4 pp |
| 2023 | 83.1% | Skr65.36 Million | Skr78.69 Million | Skr13.33 Million | ▲ +7.8 pp |
| 2022 | 75.2% | Skr103.33 Million | Skr137.36 Million | Skr34.04 Million | ▼ -17.1 pp |
| 2021 | 92.4% | Skr140.35 Million | Skr151.96 Million | Skr11.61 Million | ▲ +12.8 pp |
| 2020 | 79.5% | Skr94.55 Million | Skr118.86 Million | Skr24.31 Million | ▲ +85.3 pp |
| 2019 | -5.8% | Skr-1.08 Million | Skr18.71 Million | Skr19.79 Million | ▼ -45.4 pp |
| 2018 | 39.6% | Skr8.30 Million | Skr20.95 Million | Skr12.65 Million | ▲ +0.5 pp |
| 2017 | 39.1% | Skr6.74 Million | Skr17.23 Million | Skr10.50 Million | ▼ -13.2 pp |
| 2016 | 52.3% | Skr12.88 Million | Skr24.61 Million | Skr11.73 Million | ▲ +199.1 pp |
| 2015 | -146.8% | Skr-6.01 Million | Skr4.09 Million | Skr10.10 Million | ▼ -189.6 pp |
| 2014 | 42.8% | Skr2.35 Million | Skr5.48 Million | Skr3.13 Million | ▼ -4.2 pp |
| 2013 | 47.0% | Skr1.93 Million | Skr4.11 Million | Skr2.18 Million | — |